Medyria
not stated, CH · 2 known investors
Medyria addresses the diagnosis of angina pectoris, focusing on coronary conditions such as Coronary Artery Disease (CAD) and Non-Obstructive Coronary Artery Disease (NOCAD) linked to coronary microvascular dysfunction. The company positions itself around cardiovascular diagnostics where standard tests fail to identify NOCAD and CMD patients in time.
Investors · 2
Frequently asked questions
- What does Medyria do?
- Medyria addresses the diagnosis of angina pectoris, focusing on coronary conditions such as Coronary Artery Disease (CAD) and Non-Obstructive Coronary Artery Disease (NOCAD) linked to coronary microvascular dysfunction. The company positions itself around cardiovascular diagnostics where standard tests fail to identify NOCAD and CMD patients in time.
- Who are Medyria's investors?
- Medyria's investors include StartAngels Network, Venture Kick.
- Where is Medyria headquartered?
- Medyria is headquartered in not stated, CH.